Headlines
Graco

Graco Inc, had announced an expansion of its QUANTM pump line, aimed at boosting industrial efficiency and reliability.

Graco Inc, had announced an expansion of its QUANTM pump line, aimed at boosting industrial efficiency and reliability. The update introduces a new 480V input power option along with XTREME TORQUE (XT) motor technology, enhancing performance for demanding manufacturing environments. The QUANTM electric double diaphragm (EODD) pumps are built to support the evolving needs of…

Read More
key developments pharmaceutical industry 2025

Key Developments In The Pharmaceutical Industry 2025

Last week, several significant events in the pharmaceutical industry have captured attention, signaling important shifts in investment strategies, acquisitions, and growth phases for top companies in Asia. From strategic reorientation to major acquisitions, here’s a closer look at the key developments shaping the sector. Astellas Shifts Investment Focus Astellas, known for its cutting-edge research in…

Read More
Zimmer Biomet announces $1.2 billion acquisition of Paragon 28 to enhance its orthopedic portfolio.

Zimmer Biomet to Acquire Paragon 28 in $1.2 Billion Deal to Expand Orthopedic Portfolio

Overview On 28th January 2025, Zimmer Biomet Holdings, Inc., a leading global medical technology company, has announced a definitive agreement to acquire Paragon 28, Inc., a specialist in foot and ankle orthopedic devices, in a $1.2 billion transaction. The acquisition will be executed through an upfront cash payment of $13.00 per share, representing an equity…

Read More
Biogen and Eli Lilly Alzheimer’s drug competition, featuring Leqembi and Kisunla as leading treatments in the market.

Biogen Challenges Eli Lilly in the Alzheimer’s Treatment Race with Leqembi vs. Kisunla

As the Alzheimer’s drug market intensifies, Biogen is preparing for a fierce competition against Eli Lilly’s newly approved Alzheimer’s treatment, Kisunla. Biogen’s CEO Chris Viehbacher expressed confidence at the J.P. Morgan Healthcare Conference, stating that his company is ready to “stand our ground” in the Alzheimer’s treatment race, despite the challenge posed by Eli Lilly’s…

Read More
Top